Thomas S. Clement

No open positions remaining

70 year

Health Technology

Finance

Consumer Services

Profile

Thomas S.
Clement worked as a Quality Manager at Biotech Research Labs, Inc. from 1984 to 1988.
He then worked as a Manager-Regulatory Affairs at Amersham Corp.
in 1989.
From 1989 to 2002, he worked as a Director-Regulatory Affairs at Organon Teknika Corp.
LLC.
Later, he worked as a Vice President-Quality & Regulatory Affairs at Roche Molecular Systems, Inc. from 2002 to 2008.
In 2009 to 2011, he worked as a VP-Global Regulatory & Clinical Affairs at QIAGEN NV.
He also worked as a Vice President-Regulatory & Quality Affairs at LipoScience, Inc. Mr. Clement completed his undergraduate degree from the University of Maryland.

Former positions of Thomas S. Clement

Companies	Position	End
QIAGEN N.V.	Chief Tech/Sci/R&D Officer	2010-12-31
Roche Molecular Systems, Inc. Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms	General Counsel	2007-12-31
Organon Teknika Corp. LLC Organon Teknika Corp. LLC Financial ConglomeratesFinance Led by management of PerImmune	General Counsel	2001-12-31
Amersham Corp. Amersham Corp. Investment ManagersFinance Amersham Corp. focuses on the acquisition and ownership of mid-sized manufactures of precision engineered components and assemblies with particular interest in aerospace, automotive and medical device manufacturers and suppliers. The firm invests in small to medium sized companies with annual sales of $10 million to $200 million	General Counsel	1988-12-31
Biotech Research Labs, Inc. Biotech Research Labs, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment	Corporate Officer/Principal	1987-12-31

See the detail of Thomas S. Clement's experience

Training of Thomas S. Clement

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas S. Clement's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
QIAGEN NV QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations	Health Technology
LipoScience, Inc. LipoScience, Inc. Medical SpecialtiesHealth Technology Operates as an in vitro diagnostic company for cardiovascular and metabolic diseases using technology platform based on nuclear magnetic resonance	Health Technology
Amersham Corp. Amersham Corp. Investment ManagersFinance Amersham Corp. focuses on the acquisition and ownership of mid-sized manufactures of precision engineered components and assemblies with particular interest in aerospace, automotive and medical device manufacturers and suppliers. The firm invests in small to medium sized companies with annual sales of $10 million to $200 million	Finance
Organon Teknika Corp. LLC Organon Teknika Corp. LLC Financial ConglomeratesFinance Led by management of PerImmune	Finance
University of Maryland University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Roche Molecular Systems, Inc. Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms	Health Services
Biotech Research Labs, Inc. Biotech Research Labs, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment	Miscellaneous